来自T细胞的细胞外囊泡主要巨细胞,用于改善基于STING的癌症免疫治疗
Aida S Hansen1, Lea S Jensen1, Kristine R Gammelgaard1
1Department of Biomedicine, Aarhus University, Health, Aarhus Midtjylland, Denmark.
Journal of extracellular vesicles
|August 1, 2023
概括
激活的T细胞细胞外囊泡 (T-EVs) 重新编程巨细胞以增强STING通路激活,克服瘤免疫抑制并改善免疫治疗反应. 这提供了一种新的策略,可以促进对癌症的先天免疫反应.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
- 细胞生物学 细胞生物学
背景情况:
- 癌细胞产生一种免疫抑制性瘤微环境 (TME),阻碍免疫治疗的有效性.
- 目前的免疫疗法往往由于抗瘤免疫活性不足而失败.
- 干扰素基因刺激 (STING) 途径是触发炎症反应的目标,但单独使用STING激动剂的临床成功有限.
研究的目的:
- 研究新型辅助剂,可以增强先天免疫反应,以改善癌症免疫疗法.
- 探索来自激活CD4+T细胞 (T-EVs) 的细胞外囊泡 (EVs) 在调节瘤微环境中的潜力.
主要方法:
- 来自激活的CD4+T细胞 (T-EVs) 的细胞外囊泡 (EVs) 的表征.
- 对T-EVs对巨细胞极化和STING通路激活的影响的评估.
- 评估T-EVs携带的IFNγ作为巨细胞敏感化的媒介.
主要成果:
- 来自激活T细胞 (T-EVs) 的细胞外囊泡使巨细胞敏感,以增强STING激活.
- 由T-EVs运输的IFNγ调解了巨细胞的这种敏感化.
- T-EVs将免疫抑制性瘤相关的巨细胞重新编程为亲炎性表型.
结论:
- T-EVs可以破坏免疫抑制瘤微环境.
- 在STING激活时,T-EV的主要巨细胞提供了更强大的免疫反应.
- 这项研究提出了T-EVs作为一个有希望的辅助策略,以提高癌症免疫疗法的疗效.
相关概念视频
Tumor Immunotherapy
558
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
558
The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Cancer Vaccines
405
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
405
Cell-mediated Immune Responses
68.9K
Overview
68.9K
Cytotoxic T Cells-mediated Immune Response
972
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
972


